Virginia 2026 Session Status: In Committee

HB136 — Sickle cell disease; feasibility of Medicaid benefit and Medicaid Health Homes, report.

Last action — Left in Committee Appropriations

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House of Delegates
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill is in committee in the House of Delegates. Introduced January 03, 2026. It must pass committee before a floor vote.

Next likely step: a committee vote, then a floor vote in the House of Delegates.

Prognosis

Advancing 34% · moderate confidence

Where this bill stands today.

Odds of enactment

Low

How often bills like it became law.

  • In Committee

    Current position in the legislative process.

  • 1 sponsor

    1 primary, 0 co-sponsors signed on.

  • Cleared a recorded vote

    Passed 3 recorded votes so far.

Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.

Summary

Sickle cell disease; feasibility of Medicaid benefit and Medicaid Health Homes, report.

Bill Text

We don't have the full text on file for this bill yet.

Read HB136 on the official Virginia source →

Action History

  1. H Left in Committee Appropriations

  2. H Subcommittee recommends laying on the table (7-Y 0-N)

  3. H Placed on Appropriations Agenda

  4. H Assigned HAPP sub: Health & Human Resources

  5. H Referred to Committee on Appropriations

  6. H Reported from Health and Human Services and referred to Appropriations (20-Y 2-N)

  7. H Placed on Health and Human Services Agenda

  8. H Subcommittee recommends reporting and referring to Appropriations (8-Y 0-N)

  9. H Placed on Health and Human Services Agenda

  10. H Assigned sub: Social Services

  11. H Fiscal Impact Statement from Department of Planning and Budget (HB136)

  12. H Referred to Committee on Health and Human Services

  13. H Prefiled and ordered printed; Offered 01-14-2026 26103032D

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 147 not signed on · 2 voted No

Sponsors (1)

Co-sponsors (0)

None.

Not signed on (147)

147 members have not signed on to this bill.

Show all 147 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Votes

Passed 20 Yea · 2 Nay
Party YeaNayPresentNot Voting
Unaffiliated 20200
Total 20200
% of votes cast 91%9%0%0%
How each member voted (22)

Official roll call →

Subjects

Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HB136 do?
Sickle cell disease; feasibility of Medicaid benefit and Medicaid Health Homes, report.
Who sponsors HB136?
HB136 is sponsored by David A. Reid.
What is the current status of HB136?
This bill is in committee in the House of Delegates. Introduced January 03, 2026. It must pass committee before a floor vote.
Where can I track HB136?
Track HB136 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB136

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Stay ahead of HB136

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →